Meta-Analysis
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jul 28, 2015; 21(28): 8687-8696
Published online Jul 28, 2015. doi: 10.3748/wjg.v21.i28.8687
Figure 3
Figure 3 Three and five-year overall survival in colorectal cancer patients. A: Plot of 3-year overall survival in HER-2-positive and HER-2-negative colorectal cancer patients; B: Plot of 5-year overall survival in HER-2-positive and HER-2-negative colorectal cancer patients. HER-2: Human epidermal growth factor receptor.